Table 1 Clinicopathological characteristics of 116 patients stratified according to LVI status
Characteristic | Total | LVI positive | LVI negative | p value | |||
|---|---|---|---|---|---|---|---|
No. of patients | 116 | 30 | 86 | ||||
Age | 0.073 | ||||||
<70 years | 55 | (47.4 %) | 10 | (33.3 %) | 45 | (52.3 %) | |
≥70 years | 61 | (52.6 %) | 20 | (66.7 %) | 41 | (47.7 %) | |
Sex | 0.256 | ||||||
Male | 98 | (84.5 %) | 27 | (90.0 %) | 71 | (82.6 %) | |
Female | 18 | (15.5 %) | 3 | (10.0 %) | 15 | (17.4 %) | |
Tumor grade | 0.115 | ||||||
G1/2 | 7 | (6.0 %) | 0 | (0.0%) | 7 | (8.1 %) | |
G3 | 109 | (94.0 %) | 30 | (100.0%) | 79 | (91.9 %) | |
Concomitant CIS | 0.247 | ||||||
Positive | 26 | (22.4 %) | 9 | (30.0 %) | 17 | (19.8 %) | |
Negative | 90 | (77.6 %) | 21 | (70.0 %) | 69 | (80.2 %) | |
Multifocality | 0.638 | ||||||
Multiple | 85 | (73.3 %) | 21 | (70.0 %) | 64 | (74.4 %) | |
Solitary | 31 | (26.7 %) | 9 | (30.0 %) | 22 | (25.6 %) | |
BCG instillation | 0.334 | ||||||
Yes | 85 | (73.3 %) | 24 | (80.0 %) | 61 | (70.9 %) | |
No | 31 | (26.7 %) | 6 | (20.0 %) | 25 | (29.1 %) | |
Intravesical chemotherapy | 0.601 | ||||||
Yes | 16 | (13.8 %) | 4 | (13.3 %) | 12 | (14.0 %) | |
No | 100 | (86.2 %) | 26 | (86.7%) | 74 | (86.0 %) | |
History of Ta NMIBC | 0.418 | ||||||
Recurrence | 7 | (6.0 %) | 1 | (3.3 %) | 6 | (7.0 %) | |
Primary | 109 | (94.0 %) | 29 | (96.7 %) | 80 | (93.0 %) | |